Are you Dr. Deykin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-6987
Summary
- Dr. Aaron Deykin, MD is a pulmonologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1997- Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1995
Harvard Medical SchoolClass of 1992
Certifications & Licensure
MA State Medical License 1994 - 2024
Publications & Presentations
PubMed
- 31 citationsAn open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects.J Theodore Phillips, Edward Fox, William Grainger, Dianne Tuccillo, Shifang Liu
BMC Neurology. 2011-10-14 - 16 citationsPharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study.Xiao Hu, Yue Cui, Joleen T. White, Ying Zhu, Aaron Deykin
British Journal of Clinical Pharmacology. 2015-03-01 - 259 citationsPegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind studyPeter A. Calabresi, Bernd C. Kieseier, Douglas L. Arnold, Laura J. Balcer, Alexey Boyko
The Lancet. Neurology. 2014-07-01
Press Mentions
Comparison of Physician-, Biomarker-, and Symptom-Based Strategies for Adjustment of Inhaled Corticosteroid Therapy in Adults with AsthmaThe BASALT Randomized Controlled TrialSeptember 12th, 2012
